What Is the HPO Axis, and How Does It Affect Fertility?
The HPO axis is the signaling network between the brain, pituitary, and ovary that drives ovulation. Here is how it works, how disruption affects fertility, which tests are actually useful, and when prompt evaluation matters.
If your period is late, or it comes regularly but pregnancy still is not happening, it is easy to be told the issue is hormonal and leave it at that. But fertility does not depend on the ovary alone. Behind ovulation is a finely tuned signaling network linking the brain, pituitary gland, and ovary. This network is the hypothalamic-pituitary-ovarian axis, or HPO axis.
When this axis is working in sync, follicles mature, ovulation occurs, and progesterone rises at the right time to prepare the uterine lining. When the system is disrupted at any point, from GnRH pulses to the ovary's response, the result may be irregular cycles, infrequent ovulation, or delays in conception. In this article, you will learn what the HPO axis is, how it works, how its disruption can affect fertility, and when it deserves a structured medical evaluation.
What is the HPO axis?
HPO stands for the hypothalamic-pituitary-ovarian axis. Communication starts in the hypothalamus, which releases gonadotropin-releasing hormone, GnRH, in pulses rather than as a continuous steady signal. The anterior pituitary responds to those pulses by releasing follicle-stimulating hormone, FSH, and luteinizing hormone, LH. The ovary then receives that signal and begins follicular growth, estradiol production, ovulation, and later formation of the corpus luteum, which secretes progesterone. The pulsing pattern itself is part of the message, because continuous GnRH release does not have the same effect as regular pulses.
Put simply, the ovary does not function on its own. It responds to instructions coming from the brain, and then sends signals back in return. Those feedback signals come mainly from estradiol, progesterone, and inhibins. During most of the cycle, feedback is inhibitory, meaning it keeps FSH and LH within a range that allows selection of one dominant follicle. But just before ovulation, sustained high estradiol flips that feedback from negative to positive, triggering the LH surge that drives ovulation. A 2025 review published in Endocrinology summarizes how this axis depends on the follicle producing the right amount of sex hormones to regulate FSH and LH secretion.
How does the menstrual cycle unfold under this axis?
To understand how the axis shapes fertility, it helps to see the menstrual cycle as a linked sequence of steps:
- The hypothalamus releases GnRH in regular pulses.
- The pituitary responds by releasing FSH and LH.
- FSH supports recruitment and growth of ovarian follicles.
- Growing follicles produce estradiol and inhibin B.
- As estradiol rises early on, FSH gradually falls, which supports selection of a single dominant follicle.
- When estradiol stays high before ovulation, the LH surge occurs.
- The LH surge triggers ovulation and formation of the corpus luteum.
- The corpus luteum secretes progesterone, along with some estradiol, to stabilize the uterine lining in preparation for possible pregnancy.
- If pregnancy does not occur, the corpus luteum regresses, progesterone and estradiol fall, and menstruation begins again.
Every step matters. It is not enough for an egg to exist. It must mature at the right time, be released, and be followed by proper preparation of the uterine lining for a possible pregnancy. That is why disruption anywhere in the axis can impair fertility, even if one part of the cycle appears normal.
How does HPO axis dysfunction affect fertility?
HPO axis dysfunction is not one single disease. It is a description of a pathway that can be disrupted at multiple levels. The most common clinical result is ovulatory dysfunction, but the picture can be broader than that.
The main ways this disruption can affect fertility include:
- Absent or infrequent ovulation, meaning no fertilizable egg is released in many cycles.
- Incomplete follicular development because exposure to FSH and LH is not appropriate.
- Lower than needed progesterone after ovulation, which may affect endometrial preparation, although the diagnosis of luteal phase deficiency itself remains scientifically debated.
- Primary ovarian dysfunction, such as primary ovarian insufficiency or the menopausal transition, where feedback signaling between the ovary and brain changes.
- Hypothalamic or pituitary disorders, such as hypopituitarism, certain pituitary tumors, or hyperprolactinemia, which reduce ovarian stimulation.
- Polycystic ovary syndrome, PCOS, in which intermittent ovulation overlaps with hyperandrogenism, insulin resistance, and more complex neurohormonal signaling than a simple isolated HPO defect.
One important point is that regular monthly bleeding by itself does not prove that ovulation actually occurred. On the other hand, irregular or absent periods increase the likelihood of an ovulatory problem, but do not identify the cause. That is why the 2025 WHO guidance considers evaluation of HPO-related hormones such as FSH and LH good practice when conception is delayed and absent or infrequent ovulation is suspected, with additional tests such as TSH and prolactin depending on the clinical picture.
The most common clinical patterns of axis dysfunction
Functional hypothalamic amenorrhea
In this condition, the hypothalamic drive weakens, GnRH pulses become reduced, and FSH and LH output is low or insufficient for what the ovary needs. This can happen with low energy availability, significant weight loss, intense exercise, psychological stress, or a combination of these factors. The end result is often low estradiol and absent or infrequent ovulation.
Low estradiol here does not affect fertility alone. According to the Endocrine Society guideline, one complication is loss of bone density. That is why prolonged absence of periods should not be left unevaluated, even if you are not trying to conceive right now.
It is also important not to assume that a missed period is simply stress. Yes, stress can contribute to hypothalamic suppression, but it is not the only diagnosis. Pregnancy, thyroid disease, elevated prolactin, PCOS, and primary ovarian insufficiency all need to be ruled out first, because this is a diagnosis of exclusion.
Polycystic ovary syndrome, PCOS
PCOS is one of the most common causes of ovulatory dysfunction, but it does not look the same in every patient. According to the International Evidence-based Guideline for the Assessment and Management of PCOS (2023), diagnosis in adults is based on the presence of two of three features: ovulatory dysfunction, clinical or biochemical hyperandrogenism, and polyfollicular ovarian morphology on ultrasound, or elevated AMH as an alternative to ultrasound, after excluding other causes. The same guideline notes that PCOS prevalence may be higher in the Eastern Mediterranean region, and that it is broader than an ovulation disorder alone, with metabolic features including insulin resistance.
One of the most common misconceptions is that PCOS means permanent infertility. A more accurate way to put it is that it may reduce how often ovulation happens and therefore lengthen the time needed to conceive, but many women become pregnant spontaneously or with treatment aimed at restoring ovulation.
Primary ovarian insufficiency
Primary ovarian insufficiency means impaired ovarian function before age 40. It may present as irregular cycles, or periods that stop after previously being regular, along with low estradiol and elevated FSH. The American College of Obstetricians and Gynecologists, ACOG states that absence of menstruation, or a shift from regular to irregular cycles for three or more consecutive months without use of birth control pills or other hormonal products, warrants evaluation for all possible causes, especially in younger women, because the condition has important implications for bone health. Under the 2024 international guideline from ESHRE, ASRM, CREWHIRL and IMS, diagnosis needs at least four months of disordered cycles plus an FSH above 25 IU/L. One raised result is now enough, and a repeat after 4 to 6 weeks is used if the picture is unclear. Older guidance asked for two tests, so you may still hear that. Either way, FSH is read together with your cycle history, never alone.
This diagnosis is completely different from functional hypothalamic amenorrhea, so the two should not be lumped together under a vague label like low hormones. In functional hypothalamic amenorrhea, the problem is usually the signal coming from the brain. In primary ovarian insufficiency, the ovary itself is not responding as it should.
Pituitary disorders and high prolactin
The pituitary gland is the key relay station between GnRH and the ovary. If pituitary function is impaired, if a tumor is present, or if prolactin is elevated, FSH and LH secretion may fall, disrupting follicular growth and ovulation. A systematic review in The Journal of Clinical Endocrinology & Metabolism describes this pathway in patients with hypopituitarism.
But high prolactin does not always mean a pituitary problem. According to a review in Journal of Clinical Medicine, common causes include primary hypothyroidism and some medications, such as antipsychotics and anti-nausea drugs like metoclopramide, in addition to pregnancy and breastfeeding. That is why you should tell your doctor about every medication you take before the result is interpreted.
Clinically, some signs call for faster evaluation, such as absent periods with milk discharge from the breast, a new severe headache, or blurred vision. These are not simple signs of a temporary hormonal fluctuation. They may point to the need for a more focused pituitary workup.
How is this evaluated in practice if you are trying to conceive?
A common mistake is to look for one test called an HPO axis test. No single test summarizes the whole axis. A good evaluation combines cycle history, symptom timing, physical examination, appropriate lab testing, and sometimes ultrasound. It should also keep in mind that fertility is not only a women's issue, but also includes evaluation of your partner.
A practical checklist before your appointment
- Start by tracking your cycle carefully: Record the first day of each period, the number of days between cycles, any spotting between periods, unusual pain, symptoms such as milk discharge from the breast or headaches, increased hair growth or weight change, and all medications you take.
- Do not assume a regular period guarantees ovulation: When ovulation needs to be confirmed, the World Health Organization suggests measuring progesterone in the mid-luteal phase as presumptive confirmation. The timing is about seven days before the expected next period, not necessarily day 21 for every woman.
- Expect that some tests may need to be repeated: If progesterone is low on a single measurement, the same guidance suggests repeating it in a later cycle before diagnosing anovulation, because poor timing can create a misleading impression.
- Understand why your doctor may order more than one test: Evaluation may include a pregnancy test when a period is late, FSH and estradiol when ovarian insufficiency or hypothalamic-pituitary dysfunction is suspected, LH in selected contexts, prolactin when amenorrhea, milk discharge, or pituitary disease is suspected, and thyroid testing when symptoms or cycle patterns suggest it. The usefulness of these tests depends on timing and context, not on the number alone.
- Ask about ultrasound when it has clinical value: Ultrasound can help assess the ovaries, the uterine lining, and follicle count. It can also support diagnoses such as PCOS or help monitor follicular growth when needed.
- A fertility workup is incomplete without evaluating your partner: Semen analysis, and assessment of the fallopian tubes and uterus when indicated, are essential parts of the picture. Focusing on your hormones alone can waste valuable time.
- Seek prompt evaluation if warning signs appear: Such as a new severe headache, blurred vision, missed periods with milk discharge from the breast, severe pelvic pain, unusual bleeding, or possible pregnancy and its complications.
Common misconceptions that need correcting
- Stress alone immediately stops ovulation: Stress can contribute to hypothalamic suppression in some women, but it is not an automatic explanation for every late or missed period.
- A single FSH or LH result reveals the full status of the axis: Not true. These hormones change across the cycle and with the clinical situation, so they cannot be interpreted without timing and symptoms.
- There is a quick-fix supplement, herb, or cleanse that resets the HPO axis for everyone: There is no reliable evidence supporting a universal protocol of this kind. Real treatment depends on the cause.
- Any HPO axis problem means permanent infertility: Not necessarily. Some causes may improve when the underlying driver is treated, such as low energy availability or elevated prolactin, while others require a different path.
Bottom line
The HPO axis is not just a theoretical term from hormone textbooks. It is the system that actually drives ovulation, the menstrual cycle, and readiness for pregnancy. Most importantly, the cause cannot be guessed from one symptom or one test. Irregular or absent periods deserve evaluation to identify the reason, because treatment differs completely between low energy availability, PCOS, elevated prolactin, and ovarian insufficiency.
If none of the warning signs above apply to you and you are early in trying to conceive, the Smart Fertility Score is a ten-minute self-assessment that highlights which areas are worth discussing with your doctor. It is not a substitute for medical evaluation if your cycle is irregular or absent.
Science is the floor, not the ceiling.
Sources
- World Health Organization (2025): Guideline for the prevention, diagnosis and treatment of infertility
- Fertility and Sterility (2025): Recommendations from the WHO guideline for the prevention, diagnosis, and treatment of infertility
- Endocrinology (2025): The Hypothalamic-Pituitary-Ovarian Axis, Ovarian Disorders, and Brain Aging (Valera et al.)
- The Journal of Clinical Endocrinology & Metabolism (2020): Fertility and Pregnancy in Women With Hypopituitarism, a systematic review (Vila and Fleseriu)
- American College of Obstetricians and Gynecologists, ACOG (2014, reaffirmed 2025): Primary ovarian insufficiency in adolescents and young women
- Human Reproduction Open (2024): Evidence-based guideline on premature ovarian insufficiency (ESHRE, ASRM, CREWHIRL and IMS)
- The Journal of Clinical Endocrinology & Metabolism (2023): Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of PCOS
- The Journal of Clinical Endocrinology & Metabolism (2017): Functional Hypothalamic Amenorrhea, an Endocrine Society Clinical Practice Guideline
- Journal of Clinical Medicine (2019): Hyperprolactinaemia (Samperi, Lithgow and Karavitaki)
Follow Maha Hommos for daily evidence-based guidance: Instagram · YouTube · LinkedIn
Keep going
Watch the free masterclass on the HPO axis
60 minutes that change how you think about fertility, built on the same framework we use in clinic.
Watch now